DE69605525D1 - Bio-aromatische, eine Adamantylgruppe in para-Position enthaltende Verbindungen, diese enthaltende pharmazeutische und kosmetische Zusammensetzungen und ihre Verwendung - Google Patents
Bio-aromatische, eine Adamantylgruppe in para-Position enthaltende Verbindungen, diese enthaltende pharmazeutische und kosmetische Zusammensetzungen und ihre VerwendungInfo
- Publication number
- DE69605525D1 DE69605525D1 DE69605525T DE69605525T DE69605525D1 DE 69605525 D1 DE69605525 D1 DE 69605525D1 DE 69605525 T DE69605525 T DE 69605525T DE 69605525 T DE69605525 T DE 69605525T DE 69605525 D1 DE69605525 D1 DE 69605525D1
- Authority
- DE
- Germany
- Prior art keywords
- bio
- pharmaceutical
- aromatic compounds
- cosmetic compositions
- para position
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/94—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
- C07C235/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/20—Esters of monothiocarboxylic acids
- C07C327/32—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
- C07C47/575—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
- C07C49/83—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
- C07C65/17—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
- C07C65/24—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic
- C07C65/26—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
- C07C65/28—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups having unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9514261A FR2741876B1 (fr) | 1995-12-01 | 1995-12-01 | Composes biaromatiques portant un groupement adamantyl en para, compositions pharmaceutiques et cosmetiques les contenant et utilisations |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69605525D1 true DE69605525D1 (de) | 2000-01-13 |
DE69605525T2 DE69605525T2 (de) | 2000-05-04 |
Family
ID=9485080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69605525T Expired - Fee Related DE69605525T2 (de) | 1995-12-01 | 1996-11-13 | Biaromatische Verbindungen mit Adamantylgruppe in para-Stellung, pharmazeutische und kosmetische Zusammensetzungen, die diese enthalten, und Verwendungen |
Country Status (22)
Country | Link |
---|---|
US (1) | US5877342A (de) |
EP (1) | EP0776881B1 (de) |
JP (1) | JP2733054B2 (de) |
KR (1) | KR100236849B1 (de) |
AR (1) | AR004809A1 (de) |
AT (1) | ATE187433T1 (de) |
AU (1) | AU693045B2 (de) |
BR (1) | BR9604631A (de) |
CA (1) | CA2191790C (de) |
DE (1) | DE69605525T2 (de) |
DK (1) | DK0776881T3 (de) |
ES (1) | ES2143734T3 (de) |
FR (1) | FR2741876B1 (de) |
GR (1) | GR3032617T3 (de) |
HU (1) | HUP9603302A3 (de) |
IL (1) | IL119639A0 (de) |
NO (1) | NO307510B1 (de) |
NZ (1) | NZ299788A (de) |
PL (1) | PL185133B1 (de) |
PT (1) | PT776881E (de) |
RU (1) | RU2134256C1 (de) |
ZA (1) | ZA969717B (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9710255A (pt) * | 1996-07-08 | 1999-08-10 | Galderma Res & Dev | Método para o tratamento de cáncer composto de retinóide de adamantila composição farmacéutica ou cosmética de matéria método de tratamento ou de prevenção e método para controlar |
US6462064B1 (en) | 1996-07-08 | 2002-10-08 | Galderma Research & Development S.N.C. | Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias |
FR2757852B1 (fr) | 1996-12-31 | 1999-02-19 | Cird Galderma | Composes stilbeniques a groupement adamantyl, compositions les contenant et utilisations |
FR2763588B1 (fr) * | 1997-05-23 | 1999-07-09 | Cird Galderma | Composes triaromatiques, compositions les contenant et utilisations |
ZA994918B (en) | 1998-09-04 | 2000-02-07 | Givaudan Roure Int | New ketones. |
FR2785284B1 (fr) * | 1998-11-02 | 2000-12-01 | Galderma Res & Dev | Analogues de la vitamine d |
US6436993B1 (en) | 1999-07-13 | 2002-08-20 | The Salk Institute For Biological Studies | Use of RAR antagonists as modulators of hormone mediated processes |
FR2801307B1 (fr) | 1999-11-24 | 2002-12-06 | Galderma Res & Dev | Analogues de la vitamine d |
FR2825087B1 (fr) | 2001-05-22 | 2005-01-14 | Galderma Res & Dev | Analogues de la vitamine d |
US7449480B2 (en) * | 2002-05-14 | 2008-11-11 | Baylor College Of Medicine | Small molecule inhibitors of HER2 expression |
EP1509226A4 (de) * | 2002-05-14 | 2008-04-09 | Baylor College Medicine | Kleinmolekulare hemmer der her2 expression |
ES2275106T3 (es) | 2002-08-27 | 2007-06-01 | GALDERMA RESEARCH & DEVELOPMENT, S.N.C. | Analogos de la vitamina d. |
FR2910321B1 (fr) | 2006-12-21 | 2009-07-10 | Galderma Res & Dev S N C Snc | Gel creme comprenant au moins un retinoide et du peroxyde de benzole |
FR2910320B1 (fr) | 2006-12-21 | 2009-02-13 | Galderma Res & Dev S N C Snc | Emulsion comprenant au moins un retinoide et du peroxyde de benzole |
FR2931661B1 (fr) | 2008-05-30 | 2010-07-30 | Galderma Res & Dev | Nouvelles compositions depigmentantes sous forme d'une composition anhydre sans vaseline et sans elastomere comprenant un derive phenolique solubilise et un retinoide. |
CA2740484C (en) * | 2008-10-17 | 2021-09-21 | Akaal Pharma Pty Ltd | S1p receptors modulators and their use thereof |
WO2010042998A1 (en) | 2008-10-17 | 2010-04-22 | Akaal Pharma Pty Ltd | S1p receptors modulators |
BR112021018303A2 (pt) * | 2019-03-15 | 2021-11-23 | Massachusetts Gen Hospital | Novos inibidores de pequenas moléculas de fatores de transcrição tead |
US20220339322A1 (en) | 2019-10-02 | 2022-10-27 | Inserm (Institut National De La Santé Et De La Researche Médecale) | Use of retinoic acid receptor (rar) agonists for reversing, preventing, or delaying calcification of aortic valve |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LU87821A1 (fr) * | 1990-10-12 | 1992-05-25 | Cird Galderma | Composes bi-aromatiques,et leur utilisation en medecine humaine et veterinaire et en cosmetique |
FR2676439B1 (fr) * | 1991-05-13 | 1994-10-28 | Cird Galderma | Nouveaux composes bi-aromatiques derives d'un motif salicylique, leur procede de preparation et leur utilisation en medecine humaine et veterinaire ainsi qu'en cosmetique. |
-
1995
- 1995-12-01 FR FR9514261A patent/FR2741876B1/fr not_active Expired - Fee Related
-
1996
- 1996-11-13 AT AT96402423T patent/ATE187433T1/de not_active IP Right Cessation
- 1996-11-13 PT PT96402423T patent/PT776881E/pt unknown
- 1996-11-13 ES ES96402423T patent/ES2143734T3/es not_active Expired - Lifetime
- 1996-11-13 DK DK96402423T patent/DK0776881T3/da active
- 1996-11-13 EP EP96402423A patent/EP0776881B1/de not_active Expired - Lifetime
- 1996-11-13 DE DE69605525T patent/DE69605525T2/de not_active Expired - Fee Related
- 1996-11-18 IL IL11963996A patent/IL119639A0/xx unknown
- 1996-11-20 AU AU71871/96A patent/AU693045B2/en not_active Ceased
- 1996-11-20 ZA ZA969717A patent/ZA969717B/xx unknown
- 1996-11-20 NZ NZ299788A patent/NZ299788A/xx unknown
- 1996-11-29 HU HU9603302A patent/HUP9603302A3/hu unknown
- 1996-11-29 JP JP8320452A patent/JP2733054B2/ja not_active Expired - Fee Related
- 1996-11-29 NO NO965102A patent/NO307510B1/no not_active IP Right Cessation
- 1996-11-29 AR ARP960105416A patent/AR004809A1/es unknown
- 1996-11-29 KR KR1019960059987A patent/KR100236849B1/ko not_active IP Right Cessation
- 1996-11-29 CA CA002191790A patent/CA2191790C/fr not_active Expired - Fee Related
- 1996-11-29 BR BR9604631A patent/BR9604631A/pt not_active Application Discontinuation
- 1996-11-29 RU RU96122858A patent/RU2134256C1/ru not_active IP Right Cessation
- 1996-11-29 PL PL96317276A patent/PL185133B1/pl not_active IP Right Cessation
- 1996-12-02 US US08/757,638 patent/US5877342A/en not_active Expired - Fee Related
-
2000
- 2000-02-09 GR GR20000400316T patent/GR3032617T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US5877342A (en) | 1999-03-02 |
JPH09202744A (ja) | 1997-08-05 |
RU2134256C1 (ru) | 1999-08-10 |
MX9605916A (es) | 1998-05-31 |
HUP9603302A3 (en) | 1999-05-28 |
KR100236849B1 (ko) | 2000-03-02 |
JP2733054B2 (ja) | 1998-03-30 |
EP0776881B1 (de) | 1999-12-08 |
FR2741876A1 (fr) | 1997-06-06 |
DE69605525T2 (de) | 2000-05-04 |
PL185133B1 (pl) | 2003-02-28 |
HU9603302D0 (en) | 1997-01-28 |
DK0776881T3 (da) | 2000-04-25 |
GR3032617T3 (en) | 2000-05-31 |
KR970042508A (ko) | 1997-07-24 |
NO965102L (no) | 1997-06-02 |
IL119639A0 (en) | 1997-02-18 |
AR004809A1 (es) | 1999-03-10 |
EP0776881A1 (de) | 1997-06-04 |
ATE187433T1 (de) | 1999-12-15 |
FR2741876B1 (fr) | 1998-01-09 |
AU7187196A (en) | 1997-06-12 |
PL317276A1 (en) | 1997-06-09 |
ZA969717B (en) | 1997-06-02 |
HUP9603302A2 (en) | 1997-05-28 |
PT776881E (pt) | 2000-05-31 |
CA2191790A1 (fr) | 1997-06-02 |
ES2143734T3 (es) | 2000-05-16 |
CA2191790C (fr) | 2001-01-23 |
NZ299788A (en) | 1998-10-28 |
BR9604631A (pt) | 1998-06-23 |
AU693045B2 (en) | 1998-06-18 |
NO965102D0 (no) | 1996-11-29 |
NO307510B1 (no) | 2000-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69605525D1 (de) | Bio-aromatische, eine Adamantylgruppe in para-Position enthaltende Verbindungen, diese enthaltende pharmazeutische und kosmetische Zusammensetzungen und ihre Verwendung | |
DE69604889D1 (de) | Mit ortho-Adamantylgruppe substituierte diaromatische Verbindungen, diese enthaltende pharmazeutische und kosmetische Zusammensetzungen und Verwendungen | |
ATE250593T1 (de) | Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen | |
ATE207468T1 (de) | Aromatische verbindungen und diese enthaltende pharmazeutische zusammenstellungen | |
DE69606028T2 (de) | Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzung | |
DE69704335D1 (de) | Stilbenverbindungen mit Adamantylgruppe, diese enthaltende Zusammensetzungen und deren Verwendung | |
DE69233491D1 (de) | Pharmazeutische Zusammensetzung enthaltend S-Nitrosolipoproteine und deren Verwendung | |
ATE211132T1 (de) | Aromatische verbindungen und diese enthaltende pharmazeutische zusammenstellungen | |
DE69300913D1 (de) | Polymorph Terazosin und pharmazeutische Zusammenstellung. | |
ATE241612T1 (de) | 2-(iminoethyl)-aminophenyl - derivate, deren herstellung, deren verwendung als medikamente und diese enthaltende pharmazeutische zubereitungen | |
DE69116576T2 (de) | Aromatische sulfonamidderivate, ihre verwendung als enzyminhibitoren und diese verbindungen enthaltende pharmazeutische zusammensetzungen | |
DE69600601D1 (de) | Heterocyclische, aromatische Verbindungen, pharmazeutische und kosmetische Zusammensetzungen,die sie enthalten, und Verwendungen. | |
ATE193533T1 (de) | Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen | |
DE69600093D1 (de) | Biaromatische Amidderivate, diese enthaltende pharmazeutische und kosmetische Zusammensetzungen und ihre Verwendung | |
ATE195940T1 (de) | Taxol derivate,deren herstellung und diese enthaltende pharmazeutische zusammenstellungen | |
ATE204266T1 (de) | Taxoide, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
DE69500575D1 (de) | Neue Sonnenschutzfilter, diese enthaltende kosmetische Sonnenschutzmittel und deren Verwendungen | |
DE69611082T2 (de) | Bertholletia enthaltende kosmetische oder pharmazeutische,insbesondere dermatologische zusammensetzung | |
ATE220393T1 (de) | Eine heteroethynylen-brücke enthaltende bi- aromatische verbindungen und diese enthaltende pharmazeutische und kosmetische zusammensetzungen | |
DE69423424D1 (de) | Esculetinderivate, Verfahren zu deren Herstellung und deren Verwendung als pharmazeutische Zusammensetzungen | |
DE69942424D1 (de) | Neuartige agarofuran derivate, ihre herstellung, pharmazeutische zusammensetzungen, die diese enthalten und ihre verwendung als medizin | |
ATE204265T1 (de) | Neue taxoide, herstellung und pharmazeutische zusammensetzungen diese enthaltend | |
DE9411536U1 (de) | Kosmetische oder pharmazeutische Zusammensetzung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |